美国和中国台湾地区医学研究人员共同从中药黄芩中提取有效成分Oroxylin A,用以抑制诱导性一氧化氮制造酶,颇具治疗脑中风及心肌梗死等疾病的潜能。 美国南伊利诺伊大学和台弯地区台北医学大学、嘉义大学的研究人员共同认为,黄芩是一种相当古老的抗炎中药,在中国及亚洲其他 Medical researchers in the United States and Taiwan in China have jointly extracted Oroxylin A, an active ingredient from Astragalus membranaceus, to inhibit the production of enzymes by inducible nitric oxide, which is quite promising for the treatment of stroke and myocardial infarction. Researchers from Southern Illinois University and Taiwan University of Medicine, Taichung, Taiwan, and Chiayi University believe that Astragalus is a fairly ancient anti-inflammatory Chinese medicine in China and other Asian countries.